Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.
2.

Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer.

Zhang SJ, Hu Y, Qian HL, Jiao SC, Liu ZF, Tao HT, Han L.

Asian Pac J Cancer Prev. 2013;14(6):3937-40.

3.

Correlation of Preoperative Ki67 and Serum CA15.3 Levels with Outcome in Early Breast Cancers a Multi Institutional Study.

Rasmy A, Abozeed W, Elsamany S, Baiomy ME, Nashwa A, Amrallah A, Hasaan E, Alzahrani A, Faris M, Alsaleh K, AlFaraj A.

Asian Pac J Cancer Prev. 2016;17(7):3595-600.

4.

Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.

Shao Y, Sun X, He Y, Liu C, Liu H.

PLoS One. 2015 Jul 24;10(7):e0133830. doi: 10.1371/journal.pone.0133830. eCollection 2015.

5.

The prognostic significance of LIAISON(R) CA15-3 assay in primary breast cancer.

Nisman B, Maimon O, Allweis T, Kadouri L, Maly B, Hamburger T, Peretz T.

Anticancer Res. 2013 Jan;33(1):293-9.

PMID:
23267160
6.

HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.

Zeiwar MM, Zaki SM, Mohammad LA, Zidan AA, El Nagar MR.

Egypt J Immunol. 2007;14(2):29-41.

PMID:
20306655
7.

Elevated serum CA15-3 levels correlate with positive estrogen receptor and initial favorable outcome in patients who died from recurrent breast cancer.

Nishimura R, Nagao K, Miyayama H, Matsuda M, Baba K, Matsuoka Y, Yamashita H.

Breast Cancer. 2003;10(3):220-7.

PMID:
12955034
8.

Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.

Wang YJ, Huang XY, Mo M, Li JW, Jia XQ, Shao ZM, Shen ZZ, Wu J, Liu GY.

Asian Pac J Cancer Prev. 2015;16(11):4603-8.

9.
10.

Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.

Shiomi-Mouri Y, Kousaka J, Ando T, Tetsuka R, Nakano S, Yoshida M, Fujii K, Akizuki M, Imai T, Fukutomi T, Kobayashi K.

Breast Cancer. 2016 Jan;23(1):120-7. doi: 10.1007/s12282-014-0539-x. Epub 2014 Jun 7.

PMID:
24906662
11.

Does the pre-operative value of serum CA15-3 correlate with survival in breast cancer?

Velaiutham S, Taib NA, Ng KL, Yoong BK, Yip CH.

Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):445-8.

12.

Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game.

Gion M, Boracchi P, Dittadi R, Biganzoli E, Peloso L, Mione R, Gatti C, Paccagnella A, Marubini E.

Eur J Cancer. 2002 Jun;38(9):1181-8.

PMID:
12044503
13.

[Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].

Bensouda Y, André F, Boulet T, Al-Ghuzlan A, Conforti R, Troalen F, Bourgier C, Errihani H, Spielmann M, Delaloge S.

Bull Cancer. 2009 Oct;96(10):923-8. doi: 10.1684/bdc.2009.0919. French.

14.

[Preoperative serum CA15.3 and CEA levels and clinical-biological parameters in breast tumors].

Ruibal A, Garrido Pumar M, Arias JI.

Rev Esp Med Nucl. 2006 May-Jun;25(3):180-3. Spanish.

15.

Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.

Wang G, Qin Y, Zhang J, Zhao J, Liang Y, Zhang Z, Qin M, Sun Y.

Int J Mol Sci. 2014 May 28;15(6):9546-65. doi: 10.3390/ijms15069546.

17.

Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience.

Orucevic A, Chen J, McLoughlin JM, Heidel RE, Panella T, Bell J.

Breast J. 2015 Mar-Apr;21(2):147-54. doi: 10.1111/tbj.12367. Epub 2015 Jan 20.

PMID:
25600504
18.

Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.

Samy N, Ragab HM, El Maksoud NA, Shaalan M.

Cancer Biomark. 2010;6(2):63-72. doi: 10.3233/CBM-2009-0119.

PMID:
20571232
19.

Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis.

Arslan N, Serdar M, Deveci S, Ozturk B, Narin Y, Ilgan S, Ozturk E, Ozguven MA.

Ann Nucl Med. 2000 Oct;14(5):395-9.

PMID:
11108173
20.

The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancers.

Brouckaert O, Laenen A, Wildiers H, Floris G, Moerman P, Van Limbergen E, Vergote I, Billen J, Christiaens MR, Neven P.

Breast. 2013 Jun;22(3):254-62. doi: 10.1016/j.breast.2013.02.021. Epub 2013 Apr 6.

PMID:
23566558

Supplemental Content

Support Center